77 related articles for article (PubMed ID: 38605247)
21. Targeting TGF-β signal transduction for fibrosis and cancer therapy.
Peng D; Fu M; Wang M; Wei Y; Wei X
Mol Cancer; 2022 Apr; 21(1):104. PubMed ID: 35461253
[TBL] [Abstract][Full Text] [Related]
22. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy.
Tian Y; Xie D; Yang L
Signal Transduct Target Ther; 2022 Apr; 7(1):117. PubMed ID: 35387984
[TBL] [Abstract][Full Text] [Related]
23. Personalized chordoma organoids for drug discovery studies.
Al Shihabi A; Davarifar A; Nguyen HTL; Tavanaie N; Nelson SD; Yanagawa J; Federman N; Bernthal N; Hornicek F; Soragni A
Sci Adv; 2022 Feb; 8(7):eabl3674. PubMed ID: 35171675
[TBL] [Abstract][Full Text] [Related]
24. Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomas.
Duan W; Zhang B; Li X; Chen W; Jia S; Xin Z; Jian Q; Jian F; Chou D; Chen Z
Cancer Immunol Immunother; 2022 Sep; 71(9):2185-2195. PubMed ID: 35084549
[TBL] [Abstract][Full Text] [Related]
25. B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma.
Long C; Li G; Zhang C; Jiang T; Li Y; Duan X; Zhong G
Front Oncol; 2021; 11():659662. PubMed ID: 34868903
[TBL] [Abstract][Full Text] [Related]
26. Next frontier in tumor immunotherapy: macrophage-mediated immune evasion.
Qiu Y; Chen T; Hu R; Zhu R; Li C; Ruan Y; Xie X; Li Y
Biomark Res; 2021 Oct; 9(1):72. PubMed ID: 34625124
[TBL] [Abstract][Full Text] [Related]
27. VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding.
Lanitis E; Kosti P; Ronet C; Cribioli E; Rota G; Spill A; Reichenbach P; Zoete V; Dangaj Laniti D; Coukos G; Irving M
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34389616
[TBL] [Abstract][Full Text] [Related]
28. CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities.
Fischer JW; Bhattarai N
Front Immunol; 2021; 12():693016. PubMed ID: 34220853
[TBL] [Abstract][Full Text] [Related]
29. Integrated analysis of multimodal single-cell data.
Hao Y; Hao S; Andersen-Nissen E; Mauck WM; Zheng S; Butler A; Lee MJ; Wilk AJ; Darby C; Zager M; Hoffman P; Stoeckius M; Papalexi E; Mimitou EP; Jain J; Srivastava A; Stuart T; Fleming LM; Yeung B; Rogers AJ; McElrath JM; Blish CA; Gottardo R; Smibert P; Satija R
Cell; 2021 Jun; 184(13):3573-3587.e29. PubMed ID: 34062119
[TBL] [Abstract][Full Text] [Related]
30. The Role of Macrophages in Cancer Development and Therapy.
Cendrowicz E; Sas Z; Bremer E; Rygiel TP
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919517
[TBL] [Abstract][Full Text] [Related]
31. Novel therapies emerging in oncology to target the TGF-β pathway.
Kim BG; Malek E; Choi SH; Ignatz-Hoover JJ; Driscoll JJ
J Hematol Oncol; 2021 Apr; 14(1):55. PubMed ID: 33823905
[TBL] [Abstract][Full Text] [Related]
32. Inference and analysis of cell-cell communication using CellChat.
Jin S; Guerrero-Juarez CF; Zhang L; Chang I; Ramos R; Kuan CH; Myung P; Plikus MV; Nie Q
Nat Commun; 2021 Feb; 12(1):1088. PubMed ID: 33597522
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
34. Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC.
Le X; Nilsson M; Goldman J; Reck M; Nakagawa K; Kato T; Ares LP; Frimodt-Moller B; Wolff K; Visseren-Grul C; Heymach JV; Garon EB
J Thorac Oncol; 2021 Feb; 16(2):205-215. PubMed ID: 33096270
[TBL] [Abstract][Full Text] [Related]
35. Translational Windows in Chordoma: A Target Appraisal.
Hoffman SE; Al Abdulmohsen SA; Gupta S; Hauser BM; Meredith DM; Dunn IF; Bi WL
Front Neurol; 2020; 11():657. PubMed ID: 32733369
[TBL] [Abstract][Full Text] [Related]
36. Clinical development of therapies targeting TGFβ: current knowledge and future perspectives.
Ciardiello D; Elez E; Tabernero J; Seoane J
Ann Oncol; 2020 Oct; 31(10):1336-1349. PubMed ID: 32710930
[TBL] [Abstract][Full Text] [Related]
37. TGFβ biology in cancer progression and immunotherapy.
Derynck R; Turley SJ; Akhurst RJ
Nat Rev Clin Oncol; 2021 Jan; 18(1):9-34. PubMed ID: 32710082
[TBL] [Abstract][Full Text] [Related]
38. No convincing evidence.
Foley M
Br Dent J; 2020 Jul; 229(2):72. PubMed ID: 32710028
[No Abstract] [Full Text] [Related]
39. Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors.
Yang M; Tang X; Zhang Z; Gu L; Wei H; Zhao S; Zhong K; Mu M; Huang C; Jiang C; Xu J; Guo G; Zhou L; Tong A
Theranostics; 2020; 10(17):7622-7634. PubMed ID: 32685008
[No Abstract] [Full Text] [Related]
40. Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis.
Hung YP; Diaz-Perez JA; Cote GM; Wejde J; Schwab JH; Nardi V; Chebib IA; Deshpande V; Selig MK; Bredella MA; Rosenberg AE; Nielsen GP
Am J Surg Pathol; 2020 Sep; 44(9):1213-1223. PubMed ID: 32427623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
